The stock has just dropped some 40% to $75 a share after the FDA slapped a complete response letter (CRL) on its application for its gene therapy ...
https://www.google.com/url?rct=j&sa=t&url=https://realmoney.thestreet.com/investing/options/options-play-of-the-week-wash-rinse-repeat-15815974&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNF1FbvPK2IGce1tJVqEJxXN8C9JGA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.